By Erin Marie Daly ( January 29, 2007, 12:00 AM EST) -- Spurring widespread protests, Novartis AG on Monday filed an appeal in its ongoing battle to patent its cancer treatment Gleevec in India, asking the Madras High Court to clarify a key section of the country's patent laws governing whether companies can protect new versions of drugs whose patents have expired....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.